Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

Meeting the numerical standards can be done in a few different ways, as you have pointed out. But it has been noted before that the corporate governance requirements (of either body), including the requirement to have a majority of independent directors, one of which has financial expertise, and an annual shareholders meeting, for example, are things that could be and could have been done at any time. The decision to not do them could suggest that they feel that such things merely serve the purpose of uplisting qualifications and not the real reason to get them done....to provide adequate corporate governance.
The recent additions of a COO with expertise in infectious disease and an independent director with ocular expertise but no apparent business background would seem to show that the company is willing to share some operational duties, which strikes me as a new development, but the larger issues that fall under the corporate governance umbrella are still tightly held.
It remains to be see when that will be addressed. If the development side is progressing as quickly as we are led to believe, it would help to have some experienced business people in place to mentor that element.